Company page

Elixiron Immunotherapeutics (cayman) Limited

Elixiron Immunotherapeutics (Cayman) Limited, traded under the ticker 7871, is a public company listed on the Taiwan market. The company has a market capitalization of approximately 290.6 million USD. Elixiron focuses on developing innovative immunotherapeutic solutions.

profile7871AI content: aiUpdated May 30, 2026/company/elixiron-immunotherapeutics-inc
Elixiron Immunotherapeutics (cayman) Limited logo
Ticker
7871
Market cap
$290.6M
Sector
Health Technology
Industry
Pharmaceuticals: Major